Cargando…

Commentary: High-metastatic melanoma cells promote the metastatic capability of low-metastatic melanoma cells via exosomal transfer of miR-411-5p

Detalles Bibliográficos
Autores principales:	Li, Tianhang, Guo, Hongqian, Yang, Rong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9442040/ https://www.ncbi.nlm.nih.gov/pubmed/36072810 http://dx.doi.org/10.3389/fonc.2022.957035

Ejemplares similares

High-Metastatic Melanoma Cells Promote the Metastatic Capability of Low-Metastatic Melanoma Cells via Exosomal Transfer of miR-411-5p
por: Chen, Hao, et al.
Publicado: (2022)

Low-metastatic melanoma cells acquire enhanced metastatic capability via exosomal transfer of miR-199a-1-5p from highly metastatic melanoma cells
por: Zhao, Qiting, et al.
Publicado: (2022)

Metastatic melanoma to the proximal ureter
por: DeSanto, Matthew, et al.
Publicado: (2023)

Epigenetic Impacts of Ascorbate on Human Metastatic Melanoma Cells
por: Venturelli, Sascha, et al.
Publicado: (2014)

Association of Tumor Lysis Syndrome and Metastatic Melanoma
por: Kelkar, Neil, et al.
Publicado: (2021)

The Lymph Node Microenvironment May Invigorate Cancer Cells With Enhanced Metastatic Capacities
por: Li, Tianhang, et al.
Publicado: (2022)

Metastatic Melanoma to the Bladder: Case Report and Review of the Literature
por: Patil, Rohit V., et al.
Publicado: (2017)

Dabrafenib and Trametinib in BRAF Mutant Metastatic Conjunctival Melanoma
por: Rossi, Ernesto, et al.
Publicado: (2019)

Intermittent MEK inhibition for the treatment of metastatic uveal melanoma
por: Khan, Shaheer, et al.
Publicado: (2022)

Constitutive activation of the ETS-1-miR-222 circuitry in metastatic melanoma
por: Mattia, Gianfranco, et al.
Publicado: (2011)

Exosomal miR-125b Exerts Anti-Metastatic Properties and Predicts Early Metastasis of Hepatocellular Carcinoma
por: Kim, Hye Seon, et al.
Publicado: (2021)

Lymphatic Transport Efficiency Determines Metastatic Potential of Cutaneous Melanoma
por: Holder, Ashley M., et al.
Publicado: (2020)

The Promise of Liquid Biopsy to Predict Response to Immunotherapy in Metastatic Melanoma
por: Fattore, Luigi, et al.
Publicado: (2021)

Bladder tumour as a first manifestation of metastatic choroid melanoma
por: Vieira e Brito, Duarte, et al.
Publicado: (2022)

Combination of Ipilimumab and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic Melanoma
por: Mullinax, John E., et al.
Publicado: (2018)

The Prognostic Significance of Low-Frequency Somatic Mutations in Metastatic Cutaneous Melanoma
por: Zhao, Xiaobei, et al.
Publicado: (2019)

Robotic level II inferior vena cava thrombectomy for metastatic melanoma
por: Watson, Matthew J., et al.
Publicado: (2019)

Immunotherapy Potentiates the Effect of Chemotherapy in Metastatic Melanoma—A Retrospective Study
por: Hadash-Bengad, Reut, et al.
Publicado: (2020)

Metastatic melanoma to the bladder presenting as autonomic dysreflexia in a patient with paraplegia
por: Abdou, Cherry A., et al.
Publicado: (2021)

New panel of biomarkers to discriminate between amelanotic and melanotic metastatic melanoma
por: Militaru, Ioana V., et al.
Publicado: (2023)

Ubiquitination-related biomarkers in metastatic melanoma patients and their roles in tumor microenvironment
por: Zhang, Li, et al.
Publicado: (2023)

Imaging of metastatic melanoma
por: Michael King, D
Publicado: (2006)

Metastatic melanoma to the testis
por: Patnana, Madhavi, et al.
Publicado: (2018)

NK Cells in the Tumor Microenvironment as New Potential Players Mediating Chemotherapy Effects in Metastatic Melanoma
por: Garofalo, Cinzia, et al.
Publicado: (2021)

Advances in Personalized Targeted Treatment of Metastatic Melanoma and Non-Invasive Tumor Monitoring
por: Klinac, Dragana, et al.
Publicado: (2013)

Fibroblast Growth Factor Receptor 3 Amplified Metastatic Melanoma Treated With Erdafitinib
por: Sarkisian, Saro, et al.
Publicado: (2020)

Characterizing metastatic uveal melanoma patients who develop symptomatic brain metastases
por: Wei, Alexander Z., et al.
Publicado: (2022)

Efficacy and toxicity of Ipilimumab-Nivolumab combination therapy in elderly metastatic melanoma patients
por: Stoff, Ronen, et al.
Publicado: (2022)

Phase I trial of pembrolizumab plus vemurafenib and cobimetinib in patients with metastatic melanoma
por: Shaikh, Saba S., et al.
Publicado: (2022)

Safety and rapid response of dabrafenib and trametinib therapy during hyperbilirubinemia in metastatic melanoma
por: Shalata, Walid, et al.
Publicado: (2023)

Dendritic cell-derived exosomes (Dex) are potential biomarkers of response to Ipilimumab in metastatic melanoma
por: Stucci, Stefania, et al.
Publicado: (2015)

Temozolomide for the treatment of metastatic melanoma
por: Quirbt, I., et al.
Publicado: (2007)

Amelanotic metastatic cutaneous melanoma
por: Mendes, Marcela Sena Teixeira, et al.
Publicado: (2013)

Emergency Surgery for Metastatic Melanoma
por: Mantas, Dimitrios, et al.
Publicado: (2014)

Metastatic Cutaneous Melanoma of the Gallbladder
por: Patel, Dhruvan, et al.
Publicado: (2017)

Metastatic Melanoma With Leptomeningeal Disease
por: Marinova, Amanda M., et al.
Publicado: (2021)

Angiosarcomatous transdifferentiation of metastatic melanoma
por: Kilsdonk, Melvin J., et al.
Publicado: (2020)

Overview of Subcutaneous Metastatic Melanoma
por: Mozzillo, Nicola
Publicado: (2021)

Treatment of Advanced Metastatic Melanoma
por: Quaglino, Pietro, et al.
Publicado: (2021)

Melanoma metastatic to the hyoid bone
por: Ryan, John F., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_j7u14ndc12k3vkrn5flv29iemk